Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $222M | $321M | $359M | $299M | $248M | $242M | $268M | $321M | $349M | $419M |
| Revenue growth | — | 44.8% | 11.8% | -16.7% | -17.0% | -2.5% | 10.7% | 20.0% | 8.5% | 20.0% |
| Gross profit | $191M | $286M | $323M | $256M | $209M | $202M | $220M | $267M | $289M | $346M |
| Gross margin | 86.0% | 89.0% | 89.9% | 85.6% | 84.2% | 83.6% | 82.0% | 83.0% | 82.8% | 82.6% |
| Operating income | $884K | $46.2M | -$3.92M | -$21.2M | -$45.4M | -$7.05M | -$14.7M | $37.1M | $58.9M | $63.9M |
| Operating margin | 0.4% | 14.4% | -1.1% | -7.1% | -18.3% | -2.9% | -5.5% | 11.5% | 16.9% | 15.3% |
| Net income | $390K | $64.7M | -$30.0M | -$25.6M | -$49.3M | -$10.3M | -$30.2M | $58.2M | $42.4M | $48.6M |
| Net margin | 0.2% | 20.2% | -8.3% | -8.5% | -19.9% | -4.2% | -11.3% | 18.1% | 12.2% | 11.6% |
| EPS (diluted) | $0.00 | $0.56 | -$0.28 | -$0.24 | -$0.77 | -$0.15 | -$0.33 | $0.37 | $0.28 | $0.32 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $23.8M | $62.9M | $35.8M | -$39.4M | -$30.3M | -$1.98M | -$17.9M | $26.8M | $66.2M | $74.0M |
| Capital expenditures | — | — | — | — | — | $3.22M | $1.51M | $1.99M | — | — |
| Free cash flow | — | — | — | — | — | -$5.20M | -$19.4M | $24.8M | — | — |
| Share buybacks | $10.4M | $68.3M | $7.60M | — | $900K | $0.00 | $0.00 | $9.52M | $0.00 | $0.00 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $30.3M | $27.5M | $45.1M | $69.1M | $95.8M | $87.1M | $66.0M | $82.0M | $104M | $166M |
| Total assets | $117M | $121M | $123M | $167M | $202M | $188M | $171M | $239M | $264M | $343M |
| Total liabilities | $69.2M | $47.5M | $73.2M | $133M | $111M | $95.4M | $96.9M | $96.3M | $70.8M | $86.1M |
| Long-term debt | — | — | $0.00 | $61.9M | $47.7M | $48.1M | $48.6M | $48.1M | $17.8M | $16.5M |
| Shareholders' equity | $48.1M | $73.8M | $49.7M | $34.4M | -$150K | $82.0K | -$18.0M | $143M | $193M | $257M |
| Retained earnings | -$111M | -$46.6M | -$76.6M | -$102M | -$151M | -$162M | -$192M | -$134M | -$91.3M | -$42.7M |
| Shares (wtd avg diluted) | 113M | 116M | 106M | 107M | 108M | 110M | 113M | 146M | 149M | 150M |
Every figure is extracted from MIMEDX GROUP, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.